<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1462" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1462/" /><meta name="ncbi_pagename" content="PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/10/18" /><meta name="citation_author" content="Heather N Yeowell" /><meta name="citation_author" content="Beat Steinmann" /><meta name="citation_pmid" content="20301635" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1462/" /><meta name="citation_keywords" content="EDS, Kyphoscoliotic Form" /><meta name="citation_keywords" content="EDS Type VI" /><meta name="citation_keywords" content="EDS VI" /><meta name="citation_keywords" content="Ehlers-Danlos Syndrome Type VI" /><meta name="citation_keywords" content="kEDS" /><meta name="citation_keywords" content="Lysyl-Hydroxylase Deficiency" /><meta name="citation_keywords" content="Lysyl-Hydroxylase Deficiency" /><meta name="citation_keywords" content="EDS VI" /><meta name="citation_keywords" content="EDS Kyphoscoliotic Form" /><meta name="citation_keywords" content="EDS Type VI" /><meta name="citation_keywords" content="Ehlers-Danlos Syndrome Type VI" /><meta name="citation_keywords" content="kEDS" /><meta name="citation_keywords" content="Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" /><meta name="citation_keywords" content="PLOD1" /><meta name="citation_keywords" content="PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Heather N Yeowell" /><meta name="DC.Contributor" content="Beat Steinmann" /><meta name="DC.Date" content="2018/10/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1462/" /><meta name="description" content="PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure." /><meta name="og:title" content="PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1462/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/eds6/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1462/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B7992E040DE0100000000001D000C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1462_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1462_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/inad/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pmd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1462_"><span class="title" itemprop="name"><i>PLOD1</i>-Related Kyphoscoliotic Ehlers-Danlos Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: EDS, Kyphoscoliotic Form; EDS Type VI; EDS VI; Ehlers-Danlos Syndrome Type VI; kEDS; Lysyl-Hydroxylase Deficiency</div><p class="contrib-group"><span itemprop="author">Heather N Yeowell</span>, PhD and <span itemprop="author">Beat Steinmann</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1462_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1462_ai__"><div class="contrib half_rhythm"><span itemprop="author">Heather N Yeowell</span>, PhD<div class="affiliation small">Department of Dermatology<br />Duke University Medical Center<br />Durham, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ekud@llewoey.rehtaeh" class="oemail">ude.ekud@llewoey.rehtaeh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Beat Steinmann</span>, MD<div class="affiliation small">Division of Metabolism<br />Connective Tissue Unit<br />University Children's Hospital<br />Zurich, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="hc.hzu.ipsik@nnamniets.taeb" class="oemail">hc.hzu.ipsik@nnamniets.taeb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 2, 2000</span>; Last Revision: <span itemprop="dateModified">October 18, 2018</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="eds6.Summary" itemprop="description"><h2 id="_eds6_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>PLOD1</i>-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>PLOD1</i>-related kEDS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PLOD1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, testing for a markedly increased ratio of deoxypyridinoline to pyridinoline crosslinks in urine measured by high-performance liquid chromatography (HPLC) (a highly sensitive, specific, and inexpensive test) may be necessary for confirmation of the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management of kyphoscoliosis by an orthopedic surgeon, including surgery as needed; physical therapy to strengthen large muscle groups; bracing to support unstable joints; protective pads and helmets during active sports; control of blood pressure to reduce the risk for arterial rupture; treatment with beta blockers as needed to prevent aortic dilation.</p><p><i>Prevention of secondary complications:</i> Standard American Heart Association guidelines for antimicrobial prophylaxis for mitral valve prolapse.</p><p><i>Surveillance:</i> Regular follow up by an orthopedic surgeon for management of kyphoscoliosis; routine examination for inguinal hernia; routine ophthalmologic examination for management of myopia and early detection of glaucoma or retinal detachment; echocardiogram at five-year intervals even if the initial echocardiogram is normal.</p><p><i>Agents/circumstances to avoid</i>: Sports that stress the joints, such as gymnastics or long-distance running; high-impact sports for eye injury concerns.</p><p><i>Pregnancy management</i>: Affected pregnant women may be at increased risk for miscarriage, premature rupture of membranes, and rupture of arteries.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>PLOD1</i>-related kEDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with EDS, kyphoscoliotic form has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>PLOD1</i> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="eds6.Diagnosis"><h2 id="_eds6_Diagnosis_">Diagnosis</h2><p><i>PLOD1</i>-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, generalized joint hypermobility, skin fragility, and ocular abnormality. Pathogenic variants in <i>PLOD1</i> cause abnormal collagen biosynthesis resulting in decreased lysyl hydroxylase enzyme activity.</p><p>A disorder with a clinically overlapping <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> known as <i>FKBP14-</i>related kEDS (not addressed in this <i>GeneReview</i>) is distinguished by the presence of myopathy and hearing loss, normal lysyl hydroxylase enzyme activity, and pathogenic variants in <i>FKBP14</i>; see <a href="#eds6.Differential_Diagnosis">Differential Diagnosis</a> and <a href="/books/n/gene/fkbp14-keds/"><i>FKBP14</i>-Related Kyphoscoliotic EDS</a>.</p><div id="eds6.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>PLOD1</i>-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) <b>should be suspected</b> in individuals with the following findings [adapted from <a class="bk_pop" href="#eds6.REF.malfait.2017.8">Malfait et al 2017</a>]:</p><p><b>Major criteria</b></p><ul><li class="half_rhythm"><div>Congenital muscular hypotonia (progressive or non-progressive <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early-onset kyphoscoliosis)</div></li><li class="half_rhythm"><div>Generalized joint hypermobility with dislocations/subluxations (shoulders, hips, and knees in particular)</div></li></ul><p><b>Minor criteria</b></p><ul><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Skin fragility (easy bruising, friable skin, poor wound healing, widened atrophic scarring)</div></li><li class="half_rhythm"><div>Rupture/aneurysm of a medium-sized artery</div></li><li class="half_rhythm"><div>Osteopenia/osteoporosis</div></li><li class="half_rhythm"><div>Blue sclerae, scleral and ocular fragility/rupture</div></li><li class="half_rhythm"><div>Hernia (umbilical or inguinal)</div></li><li class="half_rhythm"><div>Pectus deformity</div></li><li class="half_rhythm"><div>Marfanoid habitus</div></li><li class="half_rhythm"><div>Talipes equinovarus</div></li><li class="half_rhythm"><div>Refractive errors (myopia, hypermetropia)</div></li><li class="half_rhythm"><div>Microcornea</div></li></ul><p><b>Minimal criteria suggestive of <i>PLOD1</i>-related kEDS</b></p><ul><li class="half_rhythm"><div>Congenital muscular hypotonia AND <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early-onset kyphoscoliosis; PLUS</div></li><li class="half_rhythm"><div>Either of the following:</div><ul><li class="half_rhythm"><div>Generalized joint hypermobility</div></li><li class="half_rhythm"><div>Three minor criteria</div></li></ul></li></ul></div><div id="eds6.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>PLOD1-</i>related kEDS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PLOD1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1462/table/eds6.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figeds6Tmoleculargenetictestingusedin" rid-ob="figobeds6Tmoleculargenetictestingusedin">Table 1</a>). If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, <a href="#eds6.Additional_Confirmatory_Testing">additional confirmatory testing</a> (e.g., measuring urinary pyridinolines) may be necessary.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>PLOD1</i>- related kEDS is broad, individuals with the distinctive findings described in <a href="#eds6.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#eds6.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited generalized connective tissue disorders are more likely to be diagnosed using genomic testing (see <a href="#eds6.Option_2">Option 2</a>).</p><div id="eds6.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of <i>PLOD1-</i>related kEDS, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PLOD1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is used to detect intragenic deletions or duplications.</div><div class="half_rhythm"><b>Note:</b> A common intragenic <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> caused by an Alu-Alu <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> in introns 9 and 16 accounts for approximately 30% (42/139) of disease alleles [<a class="bk_pop" href="#eds6.REF.yeowell.2005.353">Yeowell et al 2005</a>, <a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>]. First-tier analysis of <i>PLOD1</i>, typically sequencing, should include analysis for this duplication. If this analysis does not identify one or both pathogenic alleles in an individual, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is performed.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PLOD1</i> and other genes of interest (see <a href="#eds6.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1462/table/eds6.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figeds6Tmoleculargenetictestingusedin" rid-ob="figobeds6Tmoleculargenetictestingusedin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="eds6.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited generalized connective tissue disorders, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is non-diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="eds6.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>PLOD1</i>-related kEDS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1462/table/eds6.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds6.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLOD1</i></td><td headers="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">67%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_eds6.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="eds6.TF.1.1"><p class="no_margin">See <a href="/books/NBK1462/#eds6.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="eds6.TF.1.2"><p class="no_margin">See <a href="#eds6.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="eds6.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="eds6.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="eds6.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="eds6.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#eds6.REF.pousi.1994.899">Pousi et al [1994]</a>, <a class="bk_pop" href="#eds6.REF.pousi.1998.55">Pousi et al [1998]</a>, <a class="bk_pop" href="#eds6.REF.yeowell.2000.90">Yeowell et al [2000]</a>, <a class="bk_pop" href="#eds6.REF.giunta.2005b.269">Giunta et al [2005b]</a></p></div></dd></dl></div></div></div></div><div id="eds6.Additional_Confirmatory_Testing"><h4>Additional Confirmatory Testing</h4><p><b>Biochemical testing.</b> Deficiency of the enzyme procollagen-lysine, 2-oxoglutarate 5 dioxygenase-1 (PLOD1) results in a deficiency in hydroxylysine-based pyridinoline cross-links in collagens. Detection of an increased ratio of deoxypyridinoline (Dpyr) to pyridinoline (Pyr) cross-links in urine quantitated by high-performance liquid chromatography is a highly sensitive and specific test for <i>PLOD1</i>-related kEDS. The normal ratio of Dpyr:Pyr cross-links is approximately 0.2, whereas in kyphoscoliotic EDS the ratio is approximately 6.0 [<a class="bk_pop" href="#eds6.REF.steinmann.1995.1505">Steinmann et al 1995</a>, <a class="bk_pop" href="#eds6.REF.alhussain.2004.28">Al-Hussain et al 2004</a>]. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) can be used to detect faster migration of underhydroxylated collagen chains and their derivatives.</p></div></div></div><div id="eds6.Clinical_Characteristics"><h2 id="_eds6_Clinical_Characteristics_">Clinical Characteristics</h2><div id="eds6.Clinical_Description"><h3>Clinical Description</h3><p>A range of clinical severity is observed in individuals with <i>PLOD1</i>-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) for each of the systems discussed in this section [<a class="bk_pop" href="#eds6.REF.steinmann.2002">Steinmann et al 2002</a>, <a class="bk_pop" href="#eds6.REF.rohrbach.2011.46">Rohrbach et al 2011</a>, <a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>].</p><p><b>Prenatal.</b> Pregnancy involving an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus may be complicated by premature rupture of membranes.</p><p><b>Musculoskeletal</b></p><ul><li class="half_rhythm"><div>Muscular hypotonia with joint laxity is present in neonates.</div></li><li class="half_rhythm"><div>Muscular weakness is common, may be severe with wrist drop, and may lead to upper brachial plexus palsy.</div></li><li class="half_rhythm"><div>Gross motor delay (mild to moderate) is common.</div><ul><li class="half_rhythm"><div>Walking nearly always occurs before age two years.</div></li><li class="half_rhythm"><div>Loss of motor milestones does not occur.</div></li></ul></li><li class="half_rhythm"><div>Intellect is unaffected.</div></li><li class="half_rhythm"><div>A marfanoid habitus is often striking.</div></li><li class="half_rhythm"><div>Thoracic scoliosis is common in the neonate. The kyphoscoliosis appears during infancy and becomes moderate to severe in childhood. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure.</div></li><li class="half_rhythm"><div>Clubfoot (equinovarus) deformities are present at birth in approximately 30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Recurrent joint dislocations (associated with generalized joint hypermobility) are a common serious problem.</div></li><li class="half_rhythm"><div>Osteopenia/osteoporosis occurs in all individuals, but its clinical significance is currently unknown.</div></li></ul><p><b>Skin</b></p><ul><li class="half_rhythm"><div>All individuals with <i>PLOD1</i>-related kEDS have hyperelastic and easily stretched skin.</div></li><li class="half_rhythm"><div>An estimated 60% of individuals have abnormal scarring, characterized by thinness and widening.</div></li><li class="half_rhythm"><div>Bruising occurs easily in all individuals, and severe bruising occurs in approximately 50%.</div></li><li class="half_rhythm"><div>An equal distribution of umbilical and inguinal hernias was reported in 12 patients.</div></li></ul><p><b>Eyes</b></p><ul><li class="half_rhythm"><div>Ocular fragility (scleral as opposed to corneal), which was observed in the original reports of individuals with procollagen lysyl hydroxylase deficiency [<a class="bk_pop" href="#eds6.REF.pinnell.1972.1013">Pinnell et al 1972</a>], is found in a minority of individuals.</div></li><li class="half_rhythm"><div>Bluish sclerae are a common feature.</div></li><li class="half_rhythm"><div>High myopia is common.</div></li><li class="half_rhythm"><div>Many individuals have microcornea, although its clinical significance is unclear.</div></li><li class="half_rhythm"><div>Glaucoma and retinal detachment also occur.</div></li></ul><p><b>Cardiovascular</b></p><ul><li class="half_rhythm"><div>Vascular rupture is the major life-threatening complication in this disorder. Both aortic dilation/dissection and rupture of medium-sized arteries may occur. The rate of progression of aortic root dilation in <i>PLOD1</i>-related kEDS is not known.</div></li><li class="half_rhythm"><div>Mitral valve prolapse is common.</div></li><li class="half_rhythm"><div>Venous ectasia following use of intravenous catheters has been reported [<a class="bk_pop" href="#eds6.REF.heim.1998.708">Heim et al 1998</a>].</div></li></ul></div><div id="eds6.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been reported to date.</p></div><div id="eds6.Penetrance"><h3>Penetrance</h3><p>Penetrance for <i>PLOD1</i>-related kEDS is 100%.</p></div><div id="eds6.Nomenclature"><h3>Nomenclature</h3><p>Kyphoscoliotic EDS (kEDS) was initially referred to as EDS, oculoscoliotic form after its first description by <a class="bk_pop" href="#eds6.REF.pinnell.1972.1013">Pinnell et al [1972]</a>.</p><p>Prior to the development of the 1998 Villefranche classification, kEDS was known as EDS VI (or EDS VIA).</p><p><a class="bk_pop" href="#eds6.REF.giunta.2005a.158">Giunta et al [2005a]</a> convincingly demonstrated that Nevo syndrome is part of the spectrum of EDS VI; thus, the term "Nevo syndrome" does not refer to a distinct disorder but is now incorporated into kEDS.</p><p>In 2017, the International EDS Consortium proposed a revised EDS classification system. The new nomenclature for EDS, kyphoscoliotic form is kyphoscoliotic EDS, or kEDS [<a class="bk_pop" href="#eds6.REF.malfait.2017.8">Malfait et al 2017</a>].</p></div><div id="eds6.Prevalence"><h3>Prevalence</h3><p><i>PLOD1</i>-related kEDS is rare; the exact prevalence is unknown. A disease incidence of approximately 1:100,000 live births is a reasonable estimate.</p><p>Prevalence does not vary by race or ethnicity, although many of the reported and unreported cases originated in Turkey, the Middle East, and Greece [<a class="bk_pop" href="#eds6.REF.giunta.2005a.158">Giunta et al 2005a</a>, <a class="bk_pop" href="#eds6.REF.giunta.2005b.269">Giunta et al 2005b</a>].</p><p>Carrier frequency is estimated at 1:150.</p></div></div><div id="eds6.Genetically_Related_Allelic_Disorde"><h2 id="_eds6_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>PLOD1</i>.</p></div><div id="eds6.Differential_Diagnosis"><h2 id="_eds6_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Other forms of Ehlers-Danlos syndrome.</b> Kyphoscoliotic Ehlers-Danlos syndrome (kEDS) has some overlapping clinical features with other forms of EDS, particularly <a href="/books/n/gene/eds/">classic EDS</a> and <a href="/books/n/gene/eds4/">vascular EDS</a>. Abnormal wound healing and joint laxity are present in many EDS types. Although all types of EDS involve a relatively high risk for scoliosis compared to the general population, scoliosis in kEDS is usually more severe and of earlier onset than that seen in other EDS types.</p><p>The diagnosis of <i>PLOD1</i>-related kEDS can be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>PLOD1</i> or biochemical analysis of urinary Dpyr/Pyr cross-links.</p><p>Several rare conditions share features of <i>PLOD1</i>-related kEDS but have normal lysyl hydroxylase enzyme activity as indicated by results of the urinary Dpyr/Pyr testing. These include:</p><ul><li class="half_rhythm"><div>EDS with progressive kyphoscoliosis, myopathy, and sensorineural hearing loss caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FKBP14</i> (encoding the collagen-specific chaperone peptidyl-prolyl <i>cis-trans</i> isomerase FKBP14 [alias: FKBP22]) [<a class="bk_pop" href="#eds6.REF.baumann.2012.201">Baumann et al 2012</a>, <a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>, <a class="bk_pop" href="#eds6.REF.giunta.2018.42">Giunta et al 2018</a>]. This condition, described in 26 individuals to date, is classified as kEDS-<i>FKBP14</i> in the 2017 International Classification of the Ehlers-Danlos Syndromes [<a class="bk_pop" href="#eds6.REF.malfait.2017.8">Malfait et al 2017</a>]. See <a href="/books/n/gene/fkbp14-keds/"><i>FKBP14</i>-Related Kyphoscoliotic EDS</a>.</div></li><li class="half_rhythm"><div>Musculocontractural EDS (mcEDS; originally EDS VIB), caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CHST14</i> (encoding carbohydrate sulfotransferase 14) or <i>DSE</i> (encoding dermatan-sulfate epimerase) and characterized by additional clinical findings including adducted thumbs and feet [<a class="bk_pop" href="#eds6.REF.malfait.2010.1233">Malfait et al 2010</a>, <a class="bk_pop" href="#eds6.REF.janecke.2016.103">Janecke et al 2016</a>]</div></li><li class="half_rhythm"><div>Spondylocheirodysplastic EDS (spEDS; originally EDS VIC), including:</div><ul><li class="half_rhythm"><div>Conditions with additional progeroid characteristics caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in the galactosyl-related genes <i>B4GALT7</i> and <i>B3GALT6</i>;</div></li><li class="half_rhythm"><div>Conditions with additional clinical findings including signs of skeletal dysplasia (<i>spondylo</i>) with moderate short stature and characteristic features of the hands (thenar atrophy, <i>cheiro</i>) caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC39A13</i>, the zinc transporter <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; the urinary excretion of pyridinolines is changed to a Dpyr/Pyr ratio of approximately 1.0, falling between the ratio in controls and in kEDS [<a class="bk_pop" href="#eds6.REF.giunta.2008.1290">Giunta et al 2008</a>].</div></li></ul></li></ul><p><b>Congenital myopathies.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathies present with poor muscle tone and increased range of motion of small and large joints. Joint laxity can be difficult to distinguish from muscular hypotonia, particularly in infants and children. In kEDS, in which both hypotonia and joint laxity are present, the increased range of motion is often striking. Velvety skin texture may help distinguish kEDS from congenital myopathies such as <a href="/books/n/gene/mtm/">X-linked myotubular myopathy</a>. Unlike <a href="/books/n/gene/sma/">spinal muscular atrophy</a>, kEDS is characterized by normal deep tendon reflexes.</p><p><b>Corneal disorder.</b> Brittle cornea syndrome (BCS) is associated with corneal rupture following minor trauma (OMIM <a href="http://omim.org/entry/229200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">229200</a> and <a href="http://omim.org/entry/614170" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614170</a>). Although this disorder is also characterized by skin hyperelasticity and joint hypermobility, biochemical analysis reveals normal ratios of urinary pyridinolines and lysyl hydroxylase enzyme activity [<a class="bk_pop" href="#eds6.REF.alhussain.2004.28">Al-Hussain et al 2004</a>]. BCS is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ZNF469</i> or <i>PRDM5.</i></p><p><b>Disorders with early-onset hypotonia.</b> Many <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> and metabolic disorders include early-onset hypotonia. In these disorders, however, the other manifestations of kEDS are generally absent, and additional features are usually present.</p></div><div id="eds6.Management"><h2 id="_eds6_Management_">Management</h2><div id="eds6.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>PLOD1</i>-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) the following evaluations are recommended if not already completed:</p><ul><li class="half_rhythm"><div><b>Musculoskeletal</b></div><ul><li class="half_rhythm"><div>Evaluation for kyphoscoliosis. Photographic and radiologic documentation of the spine is recommended in view of the progressive kyphoscoliosis.</div></li><li class="half_rhythm"><div>Physical therapy evaluation to develop a plan for ongoing therapy to strengthen large muscle groups and prevent recurrent shoulder dislocation</div></li></ul></li><li class="half_rhythm"><div><b>Skin.</b> Consultation with a dermatologist to review skin findings and discuss treatment of abnormal wound healing.</div></li><li class="half_rhythm"><div><b>Ophthalmologic.</b> Formal ophthalmologic evaluation at diagnosis for myopia, astigmatism, and retinal detachment</div></li><li class="half_rhythm"><div><b>Cardiovascular.</b> Measurement of aortic root size and assessment of heart valves by echocardiogram at the time of diagnosis or by age five years</div></li><li class="half_rhythm"><div><b>Other.</b> Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="eds6.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Musculoskeletal</b></p><ul><li class="half_rhythm"><div>Refer to an orthopedic surgeon for management of kyphoscoliosis.</div></li><li class="half_rhythm"><div>Orthopedic surgery is not contraindicated in individuals with <i>PLOD1</i>-related kEDS and can be performed as necessary.</div></li><li class="half_rhythm"><div>Bracing may be required to support unstable joints.</div></li><li class="half_rhythm"><div>Physical therapy is recommended for older children, adolescents, and adults to strengthen large muscle groups, particularly at the shoulder girdle, and to prevent recurrent shoulder dislocation. Swimming is recommended.</div></li></ul><p><b>Skin</b></p><ul><li class="half_rhythm"><div>Due to skin fragility, protective pads over knees, shins, and elbows may be helpful in preventing lacerations, particularly in children.</div></li><li class="half_rhythm"><div>The use of helmets in active sports is always advised.</div></li></ul><p><b>Ophthalmologic</b></p><ul><li class="half_rhythm"><div>Myopia and/or astigmatism may be corrected by glasses or contact lenses.</div></li><li class="half_rhythm"><div>Laser treatment of the retina is indicated in case of imminent detachment.</div></li></ul><p><b>Cardiovascular</b></p><ul><li class="half_rhythm"><div>Regular monitoring by a cardiologist</div></li><li class="half_rhythm"><div>Vigilant observation and control of blood pressure can reduce the risk of arterial rupture.</div></li><li class="half_rhythm"><div>Vascular surgery is fraught with danger. While virtually no surgical literature exists on <i>PLOD1</i>-related kEDS, the review by <a class="bk_pop" href="#eds6.REF.freeman.1996.869">Freeman et al [1996]</a> on surgical complications of vascular EDS is relevant.</div></li><li class="half_rhythm"><div>Individuals with aortic dilation may require treatment with beta blockers to prevent further expansion.</div></li></ul></div><div id="eds6.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Individuals with mitral valve prolapse should follow standard American Heart Association guidelines for antimicrobial prophylaxis.</p></div><div id="eds6.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Regular follow up by an orthopedic surgeon for management of kyphoscoliosis</div></li><li class="half_rhythm"><div>Routine examination for inguinal hernia and surgical referral as necessary</div></li><li class="half_rhythm"><div>Routine ophthalmologic examination for management of myopia and early detection of glaucoma or retinal detachment</div></li><li class="half_rhythm"><div>Regular follow up by a cardiologist to monitor the echocardiogram at five-year intervals, even if the initial echocardiogram is normal</div></li><li class="half_rhythm"><div>Vigilant observation and control of blood pressure to decrease the risk of arterial rupture</div></li></ul><p>Females should be made aware of complications associated with pregnancy (see <a href="#eds6.Pregnancy_Management">Pregnancy Management</a>).</p></div><div id="eds6.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In children with significant joint hyperextensibility, sports that place stress on the joints (e.g., gymnastics, long-distance running) should be avoided.</p><p>High-impact sports should be avoided for eye injury concerns.</p></div><div id="eds6.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> / at-risk relatives in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Such an evaluation includes <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the pathogenic variants in the family are known.</p><p>See <a href="#eds6.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="eds6.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Affected pregnant women may be at increased risk for miscarriage, premature rupture of membranes, and rupture of arteries [<a class="bk_pop" href="#eds6.REF.esaka.2009.515">Esaka et al 2009</a>]. Two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women had a total of seven pregnancies resulting in three miscarriages and four healthy children, three of whom were born vaginally at term and one of whom was born at 24 weeks; there were no maternal complications [Steinmann, unpublished]. Delivery should be performed in a medical center with a high-risk perinatologist in attendance.</p></div><div id="eds6.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="eds6.Genetic_Counseling"><h2 id="_eds6_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="eds6.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>PLOD1</i>-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="eds6.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>PLOD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with <i>PLOD1</i>-related kyphoscoliotic EDS are obligate heterozygotes (carriers).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="eds6.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>PLOD1</i> pathogenic variants in the family.</p><p><b>Biochemical genetic testing.</b> Although carriers do tend to have slightly elevated urinary Dpyr/Pyr ratios [<a class="bk_pop" href="#eds6.REF.kraenzlin.2008.1546">Kraenzlin et al 2008</a>], <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status cannot be reliably ascertained by biochemical testing or by enzyme assay.</p></div><div id="eds6.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#eds6.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="eds6.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PLOD1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="eds6.Resources"><h2 id="_eds6_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association Francaise des Syndrome d'Ehlers Danlos (AFSED)</b></div><div>67, rue Jules Lecesne</div><div>Le Havre 76600</div><div>France</div><div><b>Phone:</b> 0820 20 37 33</div><div><b>Email:</b> contact@afsed.com</div><div><a href="http://afsed.fr/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.afsed.fr</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society - Europe</b></div><div>35-37 Ludgate Hill</div><div>Office 7</div><div>London EC4M 7JN</div><div>United Kingdom</div><div><b>Phone:</b> +44 203 887 6132</div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society Headquarters</b></div><div>P.O. Box 87463</div><div>Montgomery Village MD 20886</div><div><b>Phone:</b> 410-670-7577</div><div><b>Email:</b> info@ehlers-danlos.com</div><div><a href="https://ehlers-danlos.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.com</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Support Group</b></div><div>PO Box 337</div><div>Aldershot Surrey GU12 6WZ</div><div>United Kingdom</div><div><b>Phone:</b> 01252 690940</div><div><b>Email:</b> director@ehlers-danlos.org</div><div><a href="http://www.ehlers-danlos.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.org</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Support UK</b></div><div>PO Box 748</div><div>Borehamwood WD6 9HU</div><div>United Kingdom</div><div><b>Phone:</b> 0208 736 5604; 0800 9078518</div><div><a href="https://www.ehlers-danlos.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=ehlersdanlossyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos syndrome</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ehlersdanlossyndrome.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ehlers-Danlos Syndrome</a></div></li><li class="half_rhythm"><div><b>Ehlers-Danlos Society EDS &#x00026; Related Disorders Global Registry</b></div><div><a href="https://www.ehlers-danlos.com/eds-global-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ehlers-danlos.com/eds-global-registry</a></div></li></ul></div><div id="eds6.Molecular_Genetics"><h2 id="_eds6_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="eds6.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1462/table/eds6.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds6.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_eds6.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_eds6.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_eds6.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_eds6.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_eds6.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_eds6.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_eds6.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5351" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PLOD1</i></a></td><td headers="hd_b_eds6.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5351" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.22</a></td><td headers="hd_b_eds6.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q02809" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1</a></td><td headers="hd_b_eds6.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://eds.gene.le.ac.uk/home.php?select_db=PLOD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLOD1 @ LOVD</a></td><td headers="hd_b_eds6.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PLOD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLOD1</a></td><td headers="hd_b_eds6.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PLOD1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLOD1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="eds6.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="eds6.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome (<a href="/omim/153454,225400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1462/table/eds6.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds6.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/153454" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">153454</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/225400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">225400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PLOD1</i> is approximately 40 kb and consists of 19 exons with an unusually large (12.5-kb) first <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a>. The introns are of high homology, generating many potential <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> sites within the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. For a detailed summary of gene and protein information, see <a href="/books/NBK1462/#eds6.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 39 different pathogenic variants in <i>PLOD1</i> have been associated with kyphoscoliotic EDS (kEDS) [<a class="bk_pop" href="#eds6.REF.yeowell.2000.212">Yeowell &#x00026; Walker 2000</a>, <a class="bk_pop" href="#eds6.REF.giunta.2005b.269">Giunta et al 2005b</a>, <a class="bk_pop" href="#eds6.REF.walker.2005.914">Walker et al 2005</a>, <a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>]. These variants are located throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><ul><li class="half_rhythm"><div>The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, an 8.9-kb <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of seven exons (exons 10-16), is caused by a homologous <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> event between identical 44-bp Alu sequences in introns 9 and 16 [<a class="bk_pop" href="#eds6.REF.pousi.1994.899">Pousi et al 1994</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> of the duplication was 30% in probands with kEDS from 73 families [<a class="bk_pop" href="#eds6.REF.yeowell.2005.353">Yeowell et al 2005</a>, <a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>]. Intragenic deletions are also reported.</div></li><li class="half_rhythm"><div>Nine patients from six families, all of Arab descent, are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant <a class="figpopup" href="/books/NBK1462/table/eds6.T.plod1_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figeds6Tplod1pathogenicvariantsdiscuss" rid-ob="figobeds6Tplod1pathogenicvariantsdiscuss">p.Arg319Ter</a>, giving an allelic frequency of 13% [<a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>].</div></li><li class="half_rhythm"><div>The third most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PLOD1</i> is <a class="figpopup" href="/books/NBK1462/table/eds6.T.plod1_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figeds6Tplod1pathogenicvariantsdiscuss" rid-ob="figobeds6Tplod1pathogenicvariantsdiscuss">p.Tyr511Ter</a>. The <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> of this variant in probands with kEDS is 5% [<a class="bk_pop" href="#eds6.REF.brady.2017.70">Brady et al 2017</a>].</div></li></ul><p>The first and third pathogenic variants have been linked by haplotype analysis to a common ancestral <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#eds6.REF.yeowell.2000.212">Yeowell &#x00026; Walker 2000</a>].</p><div id="eds6.T.plod1_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>PLOD1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1462/table/eds6.T.plod1_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eds6.T.plod1_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8.9-kb dup exons 10-16&#x000a0;<sup>1</sup></td><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000302.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000302<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_000293.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000293<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.955C&#x0003e;T</td><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg319Ter</td></tr><tr><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1533C&#x0003e;G</td><td headers="hd_h_eds6.T.plod1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr511Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="eds6.TF.2.1"><p class="no_margin">This variant does not conform to standard nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> for <i>PLOD1</i> codes for a polypeptide of 727 amino acids, including a signal peptide of 18 residues. Lysyl hydroxylase 1 (LH1) exists as a dimer of identical subunits of molecular weight approximately 80-85 kd, depending on the state of glycosylation. The enzyme requires Fe<sup>2+</sup>, &#x003b1;-ketoglutarate, O<sub>2</sub>, and ascorbate as cofactors. The C-terminal region is well conserved across species and is thought to contain the active site of the enzyme [<a class="bk_pop" href="#eds6.REF.yeowell.2002">Yeowell 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Western blot analysis using polyclonal antibody to recombinant LH1 showed decreased levels of LH1 in two individuals with <i>PLOD1</i>-related kEDS [<a class="bk_pop" href="#eds6.REF.walker.2004.155">Walker et al 2004</a>].</p></div><div id="eds6.References"><h2 id="_eds6_References_">References</h2><div id="eds6.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.alhussain.2004.28">Al-Hussain H, Zeisberger SM, Huber PR, Giunta C, Steinmann B. Brittle cornea syndrome and its delineation from the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI): report on 23 patients and review of the literature. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">124A</span>:28–34.</span> [<a href="/pubmed/14679583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14679583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.baumann.2012.201">Baumann M, Giunta C, Krabichler B, R&#x000fc;schendorf F, Zoppi N, Colombi M, Bittner RE, Quijano-Roy S, Muntoni F, Cirak S, Schreiber G, Zou Y, Hu Y, Romero NB, Carlier RY, Amberger A, Deutschmann A, Straub V, Rohrbach M, Steinmann B, Rost&#x000e1;sy K, Karall D, B&#x000f6;nnemann CG, Zschocke J, Fauth C. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy and hearing loss. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:201–16.</span> [<a href="/pmc/articles/PMC3276673/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276673</span></a>] [<a href="/pubmed/22265013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22265013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.brady.2017.70">Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, Kosho T, Mendoza-Londono R, Pope MF, Rohrbach M, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Zschocke J, Malfait F. The Ehlers-Danlos syndromes, rare types. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2017;<span class="ref-vol">175</span>:70–115.</span> [<a href="/pubmed/28306225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.esaka.2009.515">Esaka EJ, Golde SH, Stever MR, Thomas RL. A maternal and perinatal mortality in pregnancy complicated by the kyphoscoliotic form of Ehlers-Danlos syndrome. <span><span class="ref-journal">Obstet Gynecol. </span>2009;<span class="ref-vol">113</span>:515–8.</span> [<a href="/pubmed/19155940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19155940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.freeman.1996.869">Freeman RK, Swegle J, Sise MJ. The surgical complications of Ehlers-Danlos syndrome. <span><span class="ref-journal">Am Surg. </span>1996;<span class="ref-vol">62</span>:869–73.</span> [<a href="/pubmed/8813174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8813174</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.giunta.2008.1290">Giunta C, El&#x000e7;ioglu NH, Albrecht B, Eich G, Chambaz C, Janecke AR, Yeowell H, Weis MA, Eyre DR, Kraenzlin M, Steinmann B. Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome &#x02013; an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:1290–305.</span> [<a href="/pmc/articles/PMC2427271/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427271</span></a>] [<a href="/pubmed/18513683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18513683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.giunta.2018.42">Giunta C, Baumann M, Fauth C, Lindert U, Abdalla EM, Brady AF, Collins J, Dastgir J, Donkervoort S, Ghali N, Johnson DS, Kariminejad A, Koch J, Kraenzlin M, Lahiri N, Lozic B, Manzur AY, Morton JEV, Pilch J, Pollitt RC, Schreiber G, Shannon NL, Sobey G, Vandersteen A, van Dijk FS, Witsch-Baumgartner M, Zschocke J, Pope FM, B&#x000f6;nnemann CG, Rohrbach M. A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history. <span><span class="ref-journal">Genet Med. </span>2018;<span class="ref-vol">20</span>:42–54.</span> [<a href="/pmc/articles/PMC5763155/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5763155</span></a>] [<a href="/pubmed/28617417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28617417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.giunta.2005a.158">Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA). <span><span class="ref-journal">Am J Med Genet A. </span>2005a;<span class="ref-vol">133A</span>:158–64.</span> [<a href="/pubmed/15666309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15666309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.giunta.2005b.269">Giunta C, Randolph A, Steinmann B. Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA). <span><span class="ref-journal">Mol Genet Metab. </span>2005b;<span class="ref-vol">86</span>:269–76.</span> [<a href="/pubmed/15979919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15979919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.heim.1998.708">Heim P, Raghunath M, Meiss L, Heise U, Myllyla R, Kohlschutter A, Steinmann B. Ehlers-Danlos syndrome type VI (EDS VI): problems of diagnosis and management. <span><span class="ref-journal">Acta Paediatr. </span>1998;<span class="ref-vol">87</span>:708–10.</span> [<a href="/pubmed/9686670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9686670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.janecke.2016.103">Janecke AR, Li B, Boehm M, Krabichler B, Rohrbach M, M&#x000fc;ller T, Fuchs I, Golas G, Katagiri Y, Ziegler SG, Gahl WA, Wilnai Y, Zoppi N, Geller HM, Giunta C, Slavotinek A, Steinmann B. The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:103–15.</span> [<a href="/pmc/articles/PMC5115638/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5115638</span></a>] [<a href="/pubmed/26373698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26373698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.kraenzlin.2008.1546">Kraenzlin ME, Kraenzlin CA, Meier C, Giunta C, Steinmann B. Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases. <span><span class="ref-journal">Clin Chem. </span>2008;<span class="ref-vol">54</span>:1546–53.</span> [<a href="/pubmed/18653826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18653826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.malfait.2017.8">Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B. The 2017 international classification of the Ehlers Danlos syndromes. <span><span class="ref-journal">Am J Med Genet. </span>2017;<span class="ref-vol">175</span>:8–26.</span> [<a href="/pubmed/28306229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28306229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.malfait.2010.1233">Malfait F, Syx D, Vlummens P, Symoens S, Nampoothiri S, Hermanns-L&#x000ea; T, Van Laer L, De Paepe A. Musculocontractural Ehlers-Danlos syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:1233–9.</span> [<a href="/pubmed/20842734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20842734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.pinnell.1972.1013">Pinnell SR, Krane SM, Kenzora JE, Glimcher MJ. A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease. <span><span class="ref-journal">N Engl J Med. </span>1972;<span class="ref-vol">286</span>:1013–20.</span> [<a href="/pubmed/5016372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5016372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.pousi.1994.899">Pousi B, Hautala T, Heikkinen J, Pajunen L, Kivirikko KI, Myllyla R. Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers-Danlos syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1994;<span class="ref-vol">55</span>:899–906.</span> [<a href="/pmc/articles/PMC1918329/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1918329</span></a>] [<a href="/pubmed/7977351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7977351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.pousi.1998.55">Pousi B, Hautala T, Hyland JC, Schr&#x000f6;ter J, Eckes B, Kivirikko KI, Myllyl&#x000e4; R. A compound heterozygote patient with Ehlers-Danlos syndrome type VI has a deletion in one allele and a splicing defect in the other allele of the lysyl hydroxylase gene. <span><span class="ref-journal">Hum Mutat. </span>1998;<span class="ref-vol">11</span>:55–61.</span> [<a href="/pubmed/9450904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9450904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.rohrbach.2011.46">Rohrbach M, Vandersteen A, Yi&#x0015f; U, Serdaroglu G, Ataman E, Chopra M, Garcia S, Jones K, Kariminejad A, Kraenzlin M, Marcelis C, Baumgartner M, Giunta C. Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2011;<span class="ref-vol">6</span>:46.</span> [<a href="/pmc/articles/PMC3135503/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135503</span></a>] [<a href="/pubmed/21699693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21699693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.steinmann.1995.1505">Steinmann B, Eyre DR, Shao P. Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">57</span>:1505–8.</span> [letter] [<a href="/pmc/articles/PMC1801424/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1801424</span></a>] [<a href="/pubmed/8533783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8533783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.steinmann.2002">Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos syndrome. In: Royce PM, Steinmann B, eds. <em>Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects.</em> New York, NY: Wiley-Liss; 2002:431-523.</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.walker.2005.914">Walker LC, Overstreet MA, Siddiqui A, De Paepe A, Ceylaner G, Malfait F, Symoens S, Atsawasuwan P, Yamauchi M, Ceylaner S, Bank RA, Yeowell HN. A novel mutation in the lysyl hydroxylase 1 gene causes decreased lysyl hydroxylase activity in an Ehlers-Danlos VIA patient. <span><span class="ref-journal">J Invest Dermatol. </span>2005;<span class="ref-vol">124</span>:914–8.</span> [<a href="/pubmed/15854030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15854030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.walker.2004.155">Walker LC, Overstreet MA, Willing MC, Marini JC, Cabral WA, Pals G, Bristow J, Atsawasuwan P, Yamauchi M, Yeowell HN. Heterogeneous basis of the type VIB form of Ehlers-Danlos syndrome (EDS VIB) that is unrelated to decreased collagen lysyl hydroxylation. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">131</span>:155–62.</span> [<a href="/pubmed/15523625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.yeowell.2002">Yeowell HN. Isoforms of lysyl hydroxylase. In: Creighton T, ed. <em>Wiley Encyclopedia of Molecular Medicine</em>. New York, NY: JW Wiley; 2002:1980-4.</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.yeowell.2000.212">Yeowell HN, Walker LC. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. <span><span class="ref-journal">Mol Genet Metab. </span>2000;<span class="ref-vol">71</span>:212–24.</span> [<a href="/pubmed/11001813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11001813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.yeowell.2000.90">Yeowell HN, Walker LC, Farmer B, Heikinnen J, Myllyla R. Mutational analysis of the lysyl hydroxylase 1 gene in six unrelated patients affected by Ehlers-Danlos syndrome type VI; prenatal exclusion of this disorder in one family. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">16</span>:90.</span> [<a href="/pubmed/10874315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10874315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eds6.REF.yeowell.2005.353">Yeowell HN, Walker LC, Neumann LM. An Ehlers-Danlos syndrome type VIA patient with cystic malformations of the meninges. <span><span class="ref-journal">Eur J Dermatol. </span>2005;<span class="ref-vol">15</span>:353–8.</span> [<a href="/pubmed/16172044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16172044</span></a>]</div></li></ul></div></div><div id="eds6.Chapter_Notes"><h2 id="_eds6_Chapter_Notes_">Chapter Notes</h2><div id="eds6.Author_History"><h3>Author History</h3><p>Beat Steinmann, MD (2008-present)<br />Richard Wenstrup, MD; Cincinnati Children's Hospital Medical Center (1999-2008)<br />Heather N Yeowell, PhD (2005-present)</p></div><div id="eds6.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 October 2018 (aa) Revision: new information on <i>FKBP14</i>-related kEDS [<a class="bk_pop" href="#eds6.REF.giunta.2018.42">Giunta et al 2018</a>]</div></li><li class="half_rhythm"><div>12 April 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 January 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 February 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 July 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 March 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 February 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>7 April 1999 (rw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1462</span><span class="label">PMID: <a href="/pubmed/20301635" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301635</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/inad/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pmd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1462&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1462/?report=reader">PubReader</a></li><li><a href="/books/NBK1462/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1462" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1462" style="display:none" title="Cite this Page"><div class="bk_tt">Yeowell HN, Steinmann B. PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome. 2000 Feb 2 [Updated 2018 Oct 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1462/pdf/Bookshelf_NBK1462.pdf">PDF version of this page</a> (453K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#eds6.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#eds6.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#eds6.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#eds6.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#eds6.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#eds6.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#eds6.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#eds6.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#eds6.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#eds6.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#eds6.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5351[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PLOD1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1468630" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1468630" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1468630" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1468630" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31132235" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FKBP14</i> Kyphoscoliotic Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FKBP14</i> Kyphoscoliotic Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Giunta C, Rohrbach M, Fauth C, Baumann M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31288483" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between &lt;i&gt;PLOD1&lt;/i&gt;- and &lt;i&gt;FKBP14&lt;/i&gt;-Kyphoscoliotic Ehlers-Danlos Syndrome.</a><span class="source">[Genes (Basel). 2019]</span><div class="brieflinkpop offscreen_noflow">Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between &lt;i&gt;PLOD1&lt;/i&gt;- and &lt;i&gt;FKBP14&lt;/i&gt;-Kyphoscoliotic Ehlers-Danlos Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lim PJ, Lindert U, Opitz L, Hausser I, Rohrbach M, Giunta C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genes (Basel). 2019 Jul 8; 10(7). Epub 2019 Jul 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28757364" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Ehlers Danlos syndrome, kyphoscoliotic type due to Lysyl Hydroxylase 1 deficiency in two children without congenital or early onset kyphoscoliosis.</a><span class="source">[Eur J Med Genet. 2017]</span><div class="brieflinkpop offscreen_noflow">Ehlers Danlos syndrome, kyphoscoliotic type due to Lysyl Hydroxylase 1 deficiency in two children without congenital or early onset kyphoscoliosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Dijk FS, Mancini GMS, Maugeri A, Cobben JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Med Genet. 2017 Oct; 60(10):536-540. Epub 2017 Jul 27.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25266621" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A case of Ehlers-Danlos syndrome type VIA with a novel PLOD1 gene mutation.</a><span class="source">[Pediatr Neurol. 2014]</span><div class="brieflinkpop offscreen_noflow">A case of Ehlers-Danlos syndrome type VIA with a novel PLOD1 gene mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tosun A, Kurtgoz S, Dursun S, Bozkurt G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Neurol. 2014 Oct; 51(4):566-9. Epub 2014 Jul 10.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301422" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malfait F, Wenstrup R, De Paepe A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301635" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301635" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040e2975f66d18aaa674a4">PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:34:33-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B7992E040DE0100000000001D000C&amp;ncbi_session=CE8B7992E040E281_0029SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1462%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1462&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1462/&amp;ncbi_pagename=PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B7992E040E281_0029SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>